[EN] DIFLUOROMETHOXY COMPOUND WITH LOW BIOACTIVATION POTENTIAL FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION<br/>[FR] COMPOSÉ DE DIFLUOROMÉTHOXY À FAIBLE POTENTIEL DE BIOACTIVATION DESTINÉ À RÉDUIRE LA PRODUCTION DE BÊTA-AMYLOÏDE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2015153709A1
公开(公告)日:2015-10-08
The compound N2-(3-(difluoromethoxy)-4-(3-methyl-1H-1,2,4-triazol-1-yl)phenyl)-7-(4-fluorophenyl)-N4,5,5-trimethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidine-2,4 -diamine: [PLEASE INSERT CHEMICAL STRUCTURE HERE] reduces -amyloid peptide (A 42) production and has low potential for bioactivation, and may be useful in the treatment of Alzheimer's Disease and other conditions affected by -amyloid peptide (A 42) production.
该化合物N2-(3-(二氟甲氧基)-4-(3-甲基-1H-1,2,4-三唑-1-基)苯基)-7-(4-氟苯基)-N4,5,5-三甲基-6,7-二氢-5H-环戊[d]嘧啶-2,4-二胺:[请在这里插入化学结构]能够减少-淀粉样肽(A 42)的产生,并且具有较低的生物活化潜力,可能在治疗阿尔茨海默病和其他受-淀粉样肽(A 42)产生影响的疾病中有用。